Board of Directors
Ophthalmic Orphan Programs
Gene Therapy Research
Committed to discovering and developing novel therapeutics and gene therapy solutions to treat ophthalmic diseases, with a focus on orphan and age-related retinal diseases
Ophthotech to Present at the Cowen and Company 38th Annual Health Care Conference
March 6th, 2018 07:30:00 AM
Ophthotech Reports Fourth Quarter and Full Year 2017 Financial and Operating Results
February 27th, 2018 06:33:00 AM
Ophthotech is a biopharmaceutical company specializing in the development of novel therapeutics to treat ophthalmic diseases, with a focus on orphan and age-related retinal diseases.
View Our Latest Corporate Presentation
Dr. Kourous Rezaei, Senior Vice President and Chief Medical Officer at Ophthotech. "Image en Ophtalmologie" a publication of Edimark.